Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 20/20 | 0.49 |
| ▸ | DPP9 | Q86TI2 | 11/20 | 0.45 |
| ▸ | DPP8 | Q6V1X1 | 10/20 | 0.45 |
| ▸ | DPP7 | Q9UHL4 | 10/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1240951 | 0.88 | PANK3 (0.49) | DPP4DPP9DPP8DPP7CYP2D6 | |
| SCHEMBL1243220 | 0.81 | DPP4 (0.45) | DPP4DPP9DPP8DPP7MCHR1 | |
| SCHEMBL2937242 | 0.76 | DPP4 (0.48) | DPP4DPP9DPP8DPP7CYP2D6 | |
| SCHEMBL1242542 | 0.71 | CTSD (0.47) | DPP4DPP9DPP8DPP7KCNH2 | |
| SCHEMBL1528549 | 0.70 | DPP4 (0.42) | DPP4DPP9DPP8DPP7 | |
| SCHEMBL5924085 | 0.68 | DPP4 (0.48) | DPP4DPP8DPP7CYP2D6 | |
| SCHEMBL1528449 | 0.67 | C5AR1 (0.41) | DPP4DPP9DPP8DPP7 | |
| SCHEMBL1528482 | 0.67 | C5AR1 (0.41) | DPP4DPP9DPP8DPP7 | |
| SCHEMBL1242418 | 0.66 | DPP4 (0.45) | DPP4DPP9DPP8DPP7 | |
| SCHEMBL5118281 | 0.66 | DPP4 (0.45) | DPP4DPP9DPP8DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7884104-B2 | Such as (3R,4R)-1-Pyrimidin-4-yl-4-(2,4,5-trifluorophenyl)piperidin-3-amine bis-trifluoroacetic acid salt | MERCK SHARP & DOHME CORP. (US) | 2011-02-08 | — | — | US | disclosed |
| US-20080076773-A1 | Aminopiperidines as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes | MERCK SHARP & DOHME LLC | 2008-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080076773-A1 | Aminopiperidines as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes | DPP4, DPP3, DPP7 | DPP4 1/4885DPP9 4/4885DPP8 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.